問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Veterans General Hospital (在職)

Division of Psychiatry

Tri-Service General Hospital

Division of Psychiatry

更新時間:2023-09-19

周元華Chou, Yuan-Hwa
  • Principal Investigator
  • Clinical Trial Experience (year) 23 years 9 個月

篩選

List

25Cases

2018-05-04 - 2020-12-31

Phase II

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with Schizophrenia
  • Condition/Disease

    Patients with established Schizophrenia (as per DSM-5) who are clinically stable

  • Test Drug

    BI 425809

Participate Sites
4Sites

Terminated4Sites

2008-10-01 - 2009-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated10Sites

2011-01-01 - 2012-06-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

-

IIT

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

1 2 3